Cidara Therapeutics
CDTX
CDTX
46 hedge funds and large institutions have $206M invested in Cidara Therapeutics in 2025 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 19 increasing their positions, 9 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
46
Holders Change
+6
Holders Change %
+15%
% of All Funds
0.62%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
8
Increased
19
Reduced
9
Closed
2
Calls
$64K
Puts
–
Net Calls
+$64K
Net Calls Change
+$64K
Top Buyers
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$13.4M |
| 2 |
VPC
Vestal Point Capital
New York
|
+$10.9M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$6.46M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.29M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$6.2M |
Top Sellers
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$3.62M |
| 2 |
CC
Checkpoint Capital
San Francisco,
California
|
-$1.99M |
| 3 |
SC
Stempoint Capital
New York
|
-$1.28M |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$612K |
| 5 |
Citigroup
New York
|
-$151K |
